Skip to main content

Table 3 Effect of Zingiber officinal e extracts on hepatic marker enzymes in CCl4 treated rats

From: Zingiber officinale acts as a nutraceutical agent against liver fibrosis

Parameters

Control

CCl4 group

CCl4 treated with ethanol extract

ethanol extract

CCl4 treated with chloroform extract

chloroform extract

CCl4 treated with

petroleum ether extract

CCl4 treated with silymarin

SDH

108.86 ± 24.2

(a)

84.2 ± 24.2

(b)

99.28 ± 10.05

(ab)

93.79 ± 6.79

(ab)

96.16 ± 23.51

(ab)

91.16 ± 8.29

(ab)

LDH

143.86 ± 18.12

(a)

97.01 ± 41.09

(c)

124.04 ± 27.63

(abc)

100.83 ± 12.93

(bc)

140.06 ± 2.44

(a)

131.2 ± 35.16

(ab)

G-6-Pase

43.48 ± 4.83

(a)

32.87 ± 2.24

(b)

36.97 ± 10.31

(ab)

34.07 ± 7.9

(b)

36.55 ± 2.39

(ab)

36.65 ± 6.33

(ab)

AP

63.53 ± 6.73

(a)

41.21 ± 2.55

(d)

54.3 ± 3.01

(b)

48.25 ± 3.14

(c)

48.35 ± 4.79

(c)

46.41 ± 3.19

(c)

5'NT

304.25 ± 58.81

(a)

160.83 ± 29.38

(d)

238.17 ± 5.79

(b)

215.63 ± 21.42

(bc)

192.18 ± 14.9

(cd)

214.9 ± 47.4

(bc)

  1. Data are means ± SD of eight rats in each group.
  2. Data are expressed as μmole/min/mg protein.
  3. Unshared letters between groups are the significance values at p < 0.0001.
  4. Statistical analysis is carried out using one way analysis of variance (ANOVA), CoStat Computer Program.